9-95508364-TGCCGCCGCCGCC-TGCCGCCGCCGCCGCCGCC
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000264.5(PTCH1):c.-9_-4dupGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000961 in 1,163,802 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000264.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- basal cell nevus syndrome 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- holoprosencephaly 7Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- holoprosencephalyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTCH1 | NM_000264.5 | c.-9_-4dupGGCGGC | 5_prime_UTR_variant | Exon 1 of 24 | ENST00000331920.11 | NP_000255.2 | ||
| PTCH1 | NM_001083603.3 | c.199-1771_199-1766dupGGCGGC | intron_variant | Intron 1 of 23 | ENST00000437951.6 | NP_001077072.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTCH1 | ENST00000331920.11 | c.-9_-4dupGGCGGC | 5_prime_UTR_variant | Exon 1 of 24 | 5 | NM_000264.5 | ENSP00000332353.6 | |||
| PTCH1 | ENST00000437951.6 | c.199-1771_199-1766dupGGCGGC | intron_variant | Intron 1 of 23 | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes AF: 0.00356 AC: 526AN: 147734Hom.: 4 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000670 AC: 1AN: 1492 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.000582 AC: 591AN: 1015962Hom.: 1 Cov.: 30 AF XY: 0.000530 AC XY: 255AN XY: 480704 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00356 AC: 527AN: 147840Hom.: 4 Cov.: 22 AF XY: 0.00351 AC XY: 253AN XY: 72036 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
- -
- -
- -
not provided Benign:2
PTCH1: BP4, BS1, BS2 -
- -
Gorlin syndrome Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at